Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • UNP vs MRNA✓SelectedUSD · MRNAUNP vs MRNA performance historyLatest closeAs of-1.15%11/20
Stock and ETF performance explorer

UNP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+131.0%
MRNA return
+786.4%
Excess return
-655.4%
Maximum drawdown
-38.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.1%-2.2%+1.0%-1.1%
7D-5.0%-12.7%+7.7%-4.8%
30D-0.2%-20.7%+20.5%+0.1%
3M-5.0%+46.3%-51.3%-5.8%
6M+9.2%+305.2%-296.1%+4.7%
YTD+26.1%+561.2%-535.2%+19.0%
1Y+32.6%+772.1%-739.5%+24.1%
3Y+38.8%+147.0%-108.1%+32.2%
5Y+33.3%-26.1%+59.3%+26.9%
All+131.0%+786.4%-655.4%+120.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling